NCT01558336View on ClinicalTrials.gov

Schistosoma Haematobium Infections and Praziquantel

PHASE3CompletedINTERVENTIONAL
Enrollment

520

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

August 31, 2012

Study Completion Date

September 30, 2012

Conditions
Schistosomiasis
Interventions
DRUG

praziquantel

praziquantel 40 mg/kg oral tablets

Trial Locations (1)

Unknown

Al Salamania, Al Salamania

Sponsors

Collaborators (1)

Hikma Pharmaceuticals LLC
All Listed Sponsors
collaborator

Hikma Pharmaceuticals LLC

INDUSTRY

lead

University of Khartoum

OTHER

NCT01558336 - Schistosoma Haematobium Infections and Praziquantel | Biotech Hunter | Biotech Hunter